With the prevalence of diabetes quadrupling in recent decades and currently impacting more than 500 million people in the world, it is no surprise that the technology for insulin delivery has also ...

Amazon Pharmacy has launched a new savings program for diabetic customers that automatically applies coupons on insulin and other diabetes-related products, the company announced Tuesday. The ...

Medha N. Munshi, MD, a geriatrician and endocrinologist at Beth Israel Deaconess Medical Center, has dedicated her career to improving care for older adults. In 2001, she founded the Geriatric ...

Diabetes prevalence is rising, with projections of 643 million cases by 2026 and healthcare costs exceeding $1045 billion. Nonpharmacological strategies, like Virta Health's program, demonstrate ...

The Health Endowment Fund marked World Diabetes Day, observed annually on November 14, by announcing the launch of a new fund ...

Devdatt (Dev) Kurdikar, CEO of Embecta (EMBC) said, “As our stand-up work nears completion and following an in-depth review of our portfolio and strategy, we have decided to discontinue our insulin ...

Embecta Corp., a global diabetes care company, recently announced it has received 510(k) clearance from the U.S. Food and Drug Administration for its disposable insulin delivery system. Indicated for ...

In a phase III study of adults with pre-diabetes and obesity or overweight, tirzepatide (Zepbound) reduced the risk of developing type 2 diabetes by 94% over a 3-year period, Eli Lilly announced. In ...